About this Journal Submit a Manuscript Table of Contents
Journal of Nanomaterials
Volume 2011 (2011), Article ID 768201, 7 pages
http://dx.doi.org/10.1155/2011/768201
Research Article

Nanoparticles of Conjugated Methotrexate-Human Serum Albumin: Preparation and Cytotoxicity Evaluations

1Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, P.O. Box 14155-6451, Tehran, Iran
2Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
3Department of Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
4Drug Design and Development Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
5Faculty of Medicine, Ahvaz Jundishapur University of Medical Science, P.O. Box 12244-9876, Ahvaz, Iran

Received 1 June 2010; Revised 5 July 2010; Accepted 1 August 2010

Academic Editor: Libo Wu

Copyright © 2011 Azade Taheri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Chen, B. Gu, H. Wang, J. Pan, W. Lu, and H. Hou, “Development and evaluation of novel itraconazole-loaded intravenous nanoparticles,” International Journal of Pharmaceutics, vol. 362, no. 1-2, pp. 133–140, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. S. Das, R. Banerjee, and J. Bellare, “Aspirin loaded albumin nanoparticles by coacervation: implications in drug delivery,” Trends in Biomaterials and Artificial Organs, vol. 18, no. 2, pp. 203–212, 2005. View at Scopus
  3. F. Esmaeili, R. Dinarvand, M. H. Ghahremani et al., “Docetaxel-albumin conjugates: preparation, in vitro evaluation and biodistribution studies,” Journal of Pharmaceutical Sciences, vol. 98, no. 8, pp. 2718–2730, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. T. Tanaka, P. Decuzzi, M. Cristofanilli et al., “Nanotechnology for breast cancer therapy,” Biomedical Microdevices, vol. 11, no. 1, pp. 49–63, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. R. Hertz, J. Lewis Jr., and M. B. Lipsett, “Five years' experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in women,” American Journal of Obstetrics and Gynecology, vol. 82, no. 3, pp. 631–640, 1961. View at Scopus
  6. J. R. Bertino, “Ode to methotrexate,” Journal of Clinical Oncology, vol. 11, no. 1, pp. 5–14, 1993.
  7. S. Friberg and S. Mattson, “On the growth rates of human malignant tumors: implications for medical decision making,” Journal of Surgical Oncology, vol. 65, no. 4, pp. 284–297, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Santhi, S. A. Dhanaraj, M. Koshy, S. Ponnusankar, and B. Suresh, “Study of biodistribution of methotrexate-loaded bovine serum albumin nanospheres in mice,” Drug Development and Industrial Pharmacy, vol. 26, no. 12, pp. 1293–1296, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. S. Jayaprakash, S. Mohamed Halith, P. U. Mohamed Firthouse, K. Kulaturanpillai, Abhijith, and M. Nagarajan, “Preparation and evaluation of biodegradable microspheres of methotrexate,” Asian Journal of Pharmaceutics, vol. 3, no. 1, pp. 26–29, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. L. W. Seymour, “Passive tumor targeting of soluble macromolecules and drug conjugates,” Critical Reviews in Therapeutic Drug Carrier Systems, vol. 9, no. 2, pp. 135–187, 1992. View at Scopus
  11. G. Stehle, H. Sinn, A. Wunder et al., “Plasma protein (albumin) catabolism by the tumor itself—implications for tumor metabolism and the genesis of cachexia,” Critical Reviews in Oncology/Hematology, vol. 26, no. 2, pp. 77–100, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Endo, Y. Kato, and Y. Takeda, “In vitro cytotoxicity of a human serum albumin-mediated conjugate of methotrexate with anti-MM46 monoclonal antibody,” Cancer Research, vol. 47, no. 4, pp. 1076–1080, 1987. View at Scopus
  13. F. Esmaeili, R. Dinarvand, M. H. Ghahremani, S. N. Ostad, H. Esmaily, and F. Atyabi, “Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles,” Anti-Cancer Drugs, vol. 21, no. 1, pp. 43–52, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. A. Kosasih, B. J. Bowman, R. J. Wigent, and C. M. Ofner III, “Characterization and in vitro release of methotrexate from gelatin/methotrexate conjugates formed using different preparation variables,” International Journal of Pharmaceutics, vol. 204, no. 1-2, pp. 81–89, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Nuernberg, M. Kohlbrenner, R. Faulkner, and D. Furst, “Rapid quantitation of methotrexate and its metabolites in human serum, urine and bile, using solid-phase extraction and high-performance liquid chromatography,” Journal of Chromatography, vol. 487, no. 2, pp. 476–482, 1989. View at Scopus
  16. A. F. S. A. Habeeb, “Determination of free amino groups in proteins by trinitrobenzenesulfonic acid,” Analytical Biochemistry, vol. 14, no. 3, pp. 328–336, 1966. View at Scopus
  17. N. M. Anande, S. K. Jain, and N. K. Jain, “Con-A conjugated mucoadhesive microspheres for the colonic delivery of diloxanide furoate,” International Journal of Pharmaceutics, vol. 359, no. 1-2, pp. 182–189, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. G. Yousefi, S. M. Foroutan, A. Zarghi, and A. Shafaati, “Synthesis and characterization of methotrexate polyethylene glycol esters as a drug delivery system,” Chemical and Pharmaceutical Bulletin, vol. 58, no. 2, pp. 147–153, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Wang, W. Qiao, Y. Wang, L. Yang, Y. Zhang, and P. Shao, “Cancer therapy based on nanomaterials and nanocarrier systems,” Journal of Nanomaterials, vol. 2010, Article ID 796303, 9 pages, 2010. View at Publisher · View at Google Scholar
  20. M. Brzoska, K. Langer, C. Coester, S. Loitsch, T. O. F. Wagner, and C. V. Mallinckrodt, “Incorporation of biodegradable nanoparticles into human airway epithelium cells—in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases,” Biochemical and Biophysical Research Communications, vol. 318, no. 2, pp. 562–570, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. F. Kratz, “Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles,” Journal of Controlled Release, vol. 132, no. 3, pp. 171–183, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. M. C. Garnett and R. W. Baldwin, “An improved synthesis of a methotrexate-albumin-791T/36 monoclonal antibody conjugate cytotoxic to human osteogenic sarcoma cell lines,” Cancer Research, vol. 46, no. 5, pp. 2407–2412, 1986. View at Scopus
  23. T. A. John, S. M. Vogel, C. Tiruppathi, A. B. Malik, and R. D. Minshall, “Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer,” American Journal of Physiology, vol. 284, no. 1, pp. L187–L196, 2003. View at Scopus
  24. W. Schubert, P. G. Frank, B. Razani, D. S. Park, C.-W. Chow, and M. P. Lisanti, “Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo,” Journal of Biological Chemistry, vol. 276, no. 52, pp. 48619–48622, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. N. Desai, V. Trieu, Z. Yao et al., “Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel,” Clinical Cancer Research, vol. 12, no. 4, pp. 1317–1324, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus